Subsequently, SAPs were developed with the LGS (Low Glucose Suspend) function, capable of automatically interrupting the basal insulin infusion in case of hypoglycemia, and SAPs with the PLGS (Predictive Low Glucose Suspend) function, which consists of suspending basal insulin delivery in case of hypoglycemia and predicted hypoglycemia [5,6]. Here, INS is linked to Hypoglycemia.